---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-014047"
form_type: "8-K"
ticker: "RDGL"
cik: "0001449349"
company_name: "VIVOS INC"
filed_at: "2025-09-18T23:59:59+00:00"
generated_at: "2026-05-17T06:14:06.442359+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Vivos Inc. creates wholly owned India subsidiary for manufacturing and therapies

## Summary
- Board approved creation of Vivos Scientific India LLP on September 17, 2025.
- Entity is wholly owned, aims to establish manufacturing center in India.
- Objective includes expanding human therapies and commercialization in India.
- Will generate additional human trial data to support FDA approval process.

## SEC filing metadata
- accession: 0001493152-25-014047
- form_type: 8-K
- ticker: RDGL
- cik: 0001449349
- company_name: VIVOS INC
- filed_at: 2025-09-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1449349/000149315225014047/0001493152-25-014047-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1449349/000149315225014047/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-014047
- JSON: https://secwatch.observer/filing/0001493152-25-014047.json
- Plain text: https://secwatch.observer/filing/0001493152-25-014047.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.